Edition:
United States

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

94.58USD
21 Sep 2018
Change (% chg)

$-0.46 (-0.48%)
Prev Close
$95.04
Open
$95.19
Day's High
$95.51
Day's Low
$94.48
Volume
3,617,188
Avg. Vol
1,203,177
52-wk High
$96.45
52-wk Low
$55.80

Chart for

About

Express Scripts Holding Company is a pharmacy benefit management (PBM) company. The Company is engaged in providing healthcare management and administration services to its clients, including managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $53,165.37
Shares Outstanding(Mil.): 562.12
Dividend: --
Yield (%): --

Financials

  ESRX.OQ Industry Sector
P/E (TTM): 8.89 21.89 39.45
EPS (TTM): 10.64 -- --
ROI: 17.37 10.67 60.93
ROE: 34.46 11.88 73.70

Cigna-Express scripts deal gets anti-trust approval

Sept 17 - Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing a combination the companies say will lead to lower costs by better coordinating pharmacy and medical benefits.

Sep 17 2018

Deals of the day-Mergers and acquisitions

Aug 24 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Aug 24 2018

Cigna, Express Scripts shareholders approve $52 billion deal

Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co , although the deal still needs clearance from antitrust authorities.

Aug 24 2018

UPDATE 2-Cigna, Express Scripts shareholders approve $52 bln deal

Aug 24 Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, although the deal still needs clearance from antitrust authorities.

Aug 24 2018

Cigna shareholders approve $52 bln Express Scripts acquisition

Aug 24 Cigna Corp shareholders on Friday voted in favor of the health insurer's proposed $52 billion acquisition of pharmacy benefit manager Express Scripts Holding Co, but the deal still needs antitrust approval to move forward.

Aug 24 2018

Express Scripts staking out million dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Aug 15 2018

CORRECTED--Express Scripts staking out million dollar gene therapies

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Aug 15 2018

RPT-FOCUS-Express Scripts staking out million dollar gene therapies

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Aug 15 2018

Express Scripts staking out million-dollar gene therapies

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Aug 15 2018

FOCUS-Express Scripts staking out million dollar gene therapies

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Aug 15 2018

Competitors

Earnings vs. Estimates